First-in-human phase 1/2a trial of CRLX101, a cyclodextrin-containing polymer-camptothecin nanopharmaceutical in patients with advanced solid tumor malignancies

Overview of attention for article published in Investigational New Drugs, February 2013

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (86th percentile)
Good Attention Score compared to outputs of the same age and source (75th percentile)

Mentioned by

patent: 3 patents

wikipedia: 1 Wikipedia page

Citations

dimensions_citation: 184 Dimensions

Readers on

mendeley: 138 Mendeley

Summary Patents Wikipedia Dimensions citations

So far, Altmetric has seen 3 patents that reference this research output.

Methods and systems for polymer precipitation and generation of particles

Grant US-11464871-B2

United States of America

TREATMENT OF CANCER

Application EP-3049078-A4

European Patent Office

TREATMENT OF CANCER

Application EP-3049078-A1

European Patent Office